Tissue360 Newsletter
Archive/Subscribe | TAPPI.org | Advertise | TAPPI Press Catalog October 2018

Kimberly-Clark Elects Sheri McCoy to its BOD

Print Print this Article | Send to Colleague

Kimberly-Clark Corporation has announced that Sherilyn S. "Sheri" McCoy has been elected to its board of directors, effective immediately.

"Sheri will be a great addition to our board given her global leadership experience," said Thomas J. Falk, chairman and CEO of Kimberly-Clark. "We will greatly benefit from Sheri's leadership and deep experience in consumer products and innovation as we continue to execute on our long-term growth strategy."

McCoy brings considerable consumer experience gained during a 30-year career at Johnson & Johnson, joining as a scientist in research and development, and subsequently managing businesses in every major product sector. She held global leadership posts at J&J including worldwide chairman of the Pharmaceutical Group, and head of J&J's Consumer business. Most recently, McCoy served as CEO of Avon Products, a personal care products company, until retiring earlier this year.
McCoy also serves on the boards of AstraZeneca PLC, Certara, Novocure, Stryker Corp., Catalyst and Stonehill College. She holds a Bachelor of Science degree in textile chemistry from the University of Massachusetts Dartmouth, a master's degree in chemical engineering from Princeton University, and an MBA from Rutgers University. She holds four U.S. patents.

 

Back to Tissue360 Newsletter

 
Kadant Solutions Division
Warehouse Specialist